Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul E. Freiman currently holds 29,255 shares of PENWEST PHARMACEUTICALS CO (PPCO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul E. Freiman has been a net seller of PPCO stock. They have purchased $9.9K and sold $499.7K worth of shares.
Paul E. Freiman's most recent insider trade was on Sep 3, 2009, when they sold 3,466 shares at $2.35 per share.
Paul E. Freiman serves as Executive at PENWEST PHARMACEUTICALS CO (PPCO). They have executed 69 insider transactions totaling $509.6K over their tenure at the company.
Paul E. Freiman holds the position of Executive at PENWEST PHARMACEUTICALS CO, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Paul E. Freiman has shown a selling trading pattern, with $9.9K in total purchases and $499.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul E. Freiman was on Feb 22, 2007, when they sold $191.7K worth of NTII shares. This transaction involved 109,563 shares at $1.75 per share.
Paul E. Freiman currently owns 29,255 shares of PENWEST PHARMACEUTICALS CO (PPCO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul E. Freiman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul E. Freiman has 69 Form 4 filings on record as an insider at PENWEST PHARMACEUTICALS CO.
Set alerts for Paul E. Freiman and 40,000+ other insiders.